Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Explore how patient experience data shapes regulatory drug decisions, enhancing the patient-focused drug development initiative for better treatment outcomes. Patient experience data are critical to ...

The drug development process necessitates the comprehensive evaluation of a candidate’s therapeutic benefits alongside its potential risks. Benefit–risk assessments are central to this endeavour, ...

Global harmonization of CMC guidelines is a key focus for top pharmaceutical consultants. Variations in regulatory requirements across regions often create inefficiencies in drug development—for ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

As I reflect on how we can more effectively bring treatments to patients, one central question emerges: How can we transform scientific discoveries into better treatments? The intersection of science ...

Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and medical or pharmacy claims to genomic, behavioral and sensor data. Yet it can be ...